Michele Maio

84.0k citations
376 papers · 18.5k · 7 hit papers · h-index 66

Impact in

  • Oncology top 0.05%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
  • Immunology top 0.1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 158
    • CAR-T cell therapy research 102
    • Cutaneous Melanoma Detection and Management 30
    • Melanoma and MAPK Pathways 63
    • Epigenetics and DNA Methylation 30

Michele Maio

367 papers receiving 18.1k citations

Michele Maio's Hit Papers

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study 2022 · 240 citations
2400+5+11Years since publication50010001.5k2.0k

Peers

Michele Maio
Comparison fields: 5 of 152
  • Oncology 11.4k
  • Immunology 6.9k
  • Cancer Research 1.8k
  • Molecular Biology 7.3k
  • Pulmonary and Respiratory Medicine 3.3k
Replace Ulrich Keilholz with:
Ulrich Keilholz Germany
Achim A. Jungbluth United States
John B.A.G. Haanen Netherlands
Paul B. Chapman United States
Michael A. Morse United States
Paolo A. Ascierto Italy
Alexander M.M. Eggermont Netherlands
Alfred E. Chang United States
Patrick Hwu United States
Robert H. Vonderheide United States
Michele Maio relative to Ulrich Keilholz Germany Ulrich Keilholz's profile →
Citations per field
00.5×1.5×2.1×
Ulrich Keilholz · 1×
Citations per year

Countries citing papers authored by Michele Maio

Since Specialization
Citations

This map shows the geographic impact of Michele Maio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Maio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Maio more than expected).

Fields of papers citing papers by Michele Maio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Maio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Maio. The network helps show where Michele Maio may publish in the future.

Co-authors

The 25 scholars most cited alongside Michele Maio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michele Maio Line = papers co-authored together Michele Maio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 376 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Hit paper breakdown →
20092308
2
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Hit paper breakdown →
20141491
3
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Hit paper breakdown →
2009776
4 2010415
5 2015373
6 2016311
7
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
Hit paper breakdown →
2017304
8
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Hit paper breakdown →
2016281
9 2011281
10
Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
Hit paper breakdown →
2022273
11 2013258
12
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
Hit paper breakdown →
2022240
13 2009223
14 2012221
15 2013210
16 2003206
17 2010199
18 2005195
19 1985189
20 2004170

About Michele Maio

Michele Maio is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 376 papers that have together received 18.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (158 papers), Immunotherapy and Immune Responses (120 papers), CAR-T cell therapy research (102 papers), Melanoma and MAPK Pathways (63 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), Cutaneous Melanoma Detection and Management (30 papers), Epigenetics and DNA Methylation (30 papers) and Immune Cell Function and Interaction (30 papers). The work is most often cited by research in Oncology (11.4k citations), Immunology (6.9k citations), Cancer Research (1.8k citations), Molecular Biology (7.3k citations) and Pulmonary and Respiratory Medicine (3.3k citations). Michele Maio has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Maresa Altomonte, Ester Fonsatti, Jedd D. Wolchok, Anna Maria Di Giacomo, Luca Sigalotti, Célèste Lebbé, Omid Hamid, Luana Calabrò, Jeffrey S. Weber and Sandra Coral. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Cellular Physiology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact